Arcoma (ARCOMA) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
5 Jun, 2025Executive summary
Strong demand persisted, but slower installation pace in the US slightly dampened the quarter.
Profitability remained solid despite lower revenue compared to a strong prior-year quarter.
Product innovation continued, with a new 3D camera application showcased and planned for launch in autumn.
Financial highlights
Net revenue for Q1 2025 was 34,875 KSEK, down from 46,464 KSEK year-over-year.
EBITDA reached 4,458 KSEK (12% margin), compared to 6,493 KSEK (14%) last year.
EBIT was 2,587 KSEK, down from 4,448 KSEK; net income was 2,044 KSEK versus 3,594 KSEK.
Earnings per share were 0.16 SEK, compared to 0.27 SEK in Q1 2024.
Cash flow for the quarter was -4,785 KSEK, mainly due to a temporarily high inventory.
Outlook and guidance
Entering the next quarter with a strong project pipeline and high market presence.
Underlying demand in North America remains robust, though installation timing is a challenge.
EMEA market conditions are improving, but market turbulence may delay purchasing decisions.
Latest events from Arcoma
- Q1 revenue fell 11% but profitability and strong cash position were maintained.ARCOMA
Q1 202623 Apr 2026 - Profitability and strong cash flow in 2025, with growth in Europe but declines in other regions.ARCOMA
Q4 202512 Feb 2026 - Q3 saw stable margins and strong US growth, but overall sales and profit declined year-over-year.ARCOMA
Q3 202523 Oct 2025 - European growth offset by sharp declines in US and Asia; profitability maintained via cost control.ARCOMA
Q2 202521 Aug 2025 - Stable EBITDA and strong aftermarket growth offset lower Q3 sales; debt fully repaid.ARCOMA
Q3 202413 Jun 2025 - Q2 sales up 9%, EBITDA up 103%, with strong growth in North America and Asia.ARCOMA
Q2 202413 Jun 2025 - Record profit and improved margins in 2024, with strong financial stability and growth outlook.ARCOMA
Q4 20245 Jun 2025